Your browser doesn't support javascript.
loading
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans.
Tammen, Harald; Kömhoff, Martin; Delic, Denis; Lund, Søren S; Hocher, Berthold; Frankenreiter, Sandra; Hess, Rüdiger; von Eynatten, Maximilian; Mark, Michael; Klein, Thomas.
Afiliação
  • Tammen H; PXBioVisioN GmbH, Feodor-Lynen-Straße 31, 30625, Hannover, Germany. htammen@pxbiovision.com.
  • Kömhoff M; Department of Pediatrics, University Marburg, Marburg, Germany.
  • Delic D; Boehringer Ingelheim GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Germany.
  • Lund SS; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Hocher B; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
  • Frankenreiter S; Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China.
  • Hess R; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China.
  • von Eynatten M; Institute of Medical Diagnostics, IMD Berlin, Berlin, Germany.
  • Mark M; Boehringer Ingelheim GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Germany.
  • Klein T; PXBioVisioN GmbH, Feodor-Lynen-Straße 31, 30625, Hannover, Germany.
Sci Rep ; 13(1): 601, 2023 01 12.
Article em En | MEDLINE | ID: mdl-36635409
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha